• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Listar

    Todo UVaDOCComunidadesPor fecha de publicaciónAutoresMateriasTítulos

    Mi cuenta

    Acceder

    Estadísticas

    Ver Estadísticas de uso

    Compartir

    Ver ítem 
    •   UVaDOC Principal
    • PRODUCCIÓN CIENTÍFICA
    • Departamentos
    • Dpto. Biología Celular, Genética, Histología y Farmacología
    • DEP05 - Artículos de revista
    • Ver ítem
    •   UVaDOC Principal
    • PRODUCCIÓN CIENTÍFICA
    • Departamentos
    • Dpto. Biología Celular, Genética, Histología y Farmacología
    • DEP05 - Artículos de revista
    • Ver ítem
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Exportar

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/73822

    Título
    Human Health Effects of Lactose Consumption as a Food and Drug Ingredient
    Autor
    Seoane, Rafael G.
    Garcia-Recio, Verónica
    Garrosa, Manuel
    Rojo, María Á.
    Jiménez, Pilar
    Girbés, Tomás
    Cordoba-Diaz, Manuel
    Cordoba-Diaz, Damián
    Año del Documento
    2020
    Editorial
    Bentham Science
    Descripción
    Producción Científica
    Documento Fuente
    Current Pharmaceutical Design, 2020, vol. 26, n. 16. p 1778-1789
    Resumen
    Lactose is a reducing sugar consisting of galactose and glucose, linked by a β (1→4) glycosidic bond, considered as an antioxidant due to its α-hydroxycarbonyl group. Lactose is widely ingested through the milk and other unfermented dairy products and is considered to be one of the primary foods. On the other hand, lactose is also considered as one of the most widely used excipients for the development of pharmaceutical formulations. In this sense, lactose has been related to numerous drug-excipient or drug-food pharmacokinetic interactions. Intolerance, maldigestion and malabsorption of carbohydrates are common disorders in clinical practice, with lactose-intolerance being the most frequently diagnosed, afflicting 10% of the world’s population. Four clinical subtypes of lactose intolerance may be distinguished, namely lactase deficiency in premature infants, congenital lactase deficiency, adult-type hypolactasia and secondary lactase intolerance. An overview of the main uses of lactose in human nutrition and in the pharmaceutical industry and the problems derived from this circumstance are described.
    Palabras Clave
    Lactose, antioxidant, excipient, food, interaction, intolerance
    ISSN
    1381-6128
    Revisión por pares
    SI
    DOI
    10.2174/1381612826666200212114843
    Propietario de los Derechos
    Bentham Science Publishers
    Idioma
    eng
    URI
    https://uvadoc.uva.es/handle/10324/73822
    Tipo de versión
    info:eu-repo/semantics/publishedVersion
    Derechos
    restrictedAccess
    Aparece en las colecciones
    • DEP05 - Artículos de revista [198]
    Mostrar el registro completo del ítem
    Ficheros en el ítem
    Nombre:
    Curr Pharm Desg 202026 1778-89.pdf
    Tamaño:
    1.939Mb
    Formato:
    Adobe PDF
    Thumbnail
    Visualizar/Abrir

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10